7/12/2007

ValueAct Capital, a private equity firm that owns 14.7% of Advanced Medical Optics shares, has announced it plans to vote against AMO's plan to buy Bausch & Lomb. The shareholder says the purchase would be an "substantial" risk.

Related Summaries